Ling Li, MD, PhD; Wei Zhang, MD; Yu Hu, MD, PhD; et al.
doi : 10.1001/jama.2020.10044
JAMA. 2020;324(5):471-480.
This randomized trial compares the effects of convalescent plasma therapy with standard care vs standard care alone on time to clinical improvement among patients with severe or life-threatening COVID-19 disease in China.
Olivia I. Okereke, MD, SM; Charles F. Reynolds III, MD; David Mischoulon, MD, PhD; et al.
doi : 10.1001/jama.2020.10224
JAMA. 2020;324(5):481-487.
This randomized clinical trial compares the effects of vitamin D? supplementation vs placebo on depression risk and mood scores in men and women aged 50 years or older.
Cyrus M. Kosar, MA; Lacey Loomer, PhD, MSPH; Kali S. Thomas, PhD; et al.
doi : 10.1001/jama.2020.9935
JAMA. 2020;324(5):481-487.
This study uses Medicare data to estimate mortality differences for common medical conditions (pneumonia, heart failure, chronic obstructive pulmonary disease, urinary tract infection, others) at US critical access vs non–critical access hospitals between 2007 and 2017 with vs without adjustment for discharge diagnosis counts to assess the extent to which coding practices rather than illness severity might account for observed mortality differences.
Michael L. Barnett, MD, MS; Lissy Hu, MD; Thomas Martin, MS; et al.
doi : 10.1001/jama.2020.11642
JAMA. 2020;324(5):507-509.
This study uses Medicare’s Nursing Home Compare and a university long-term care database to compare census, admissions, discharges, and mortality at skilled nursing facilities (SNFs) in 3 metropolitan areas during March-May 2020 vs March-May 2019.
Steven H. Woolf, MD, MPH; Derek A. Chapman, PhD; Roy T. Sabo, PhD; et al.
doi : 10.1001/jama.2020.11787
JAMA. 2020;324(5):510-513.
This study uses data from the National Center for Health Statistics to estimate excess deaths (ie, the difference between observed and expected deaths) in the US and the District of Columbia in the early weeks of the COVID-19 pandemic.
Walter Hsiang, BS; Grace Jin, BS; Howard Forman, MD, MBA; et al.
doi : 10.1001/jama.2020.7317
JAMA. 2020;324(5):513-514.
This study uses simulated patient phone calls to a random selection of US urgent care clinics (UCCs) to describe the proportion that offer membership programs with access to discounted visits for recurring fees and the characteristics (affiliations, accreditations, population income) and fees and charges of those that do.
Clyde W. Yancy, MD, MSc
doi : 10.1001/jama.2020.12532
JAMA. 2020;324(5):435-436.
In the context of the Black Lives Matter movement, this Viewpoint considers the demand that academic medicine address its own structural racism, and concludes on the basis of its history, culture, role, and influence that the institution can, should, and must make racial justice a part of its work and mission.
Kevin P. O’Callaghan, MB, BCh, BAO; Allison M. Blatz, MD; Paul A. Offit, MD
doi : 10.1001/jama.2020.12190
JAMA. 2020;324(5):437-438.
This Viewpoint discusses the mechanisms of the 5 leading COVID-19 vaccine candidates—2 messenger RNA vaccines, 1 recombinant VSV vector product, and 2 replication-defective adenovirus vector approaches—and emphasizes the need to demonstrate safety as well as efficacy to facilitate broad uptake by the public.
Nicole Lurie, MD, MSPH; Joshua M. Sharfstein, MD; Jesse L. Goodman, MD, MPH
doi : 10.1001/jama.2020.12461
JAMA. 2020;324(5):439-440.
This Viewpoint lists 4 safeguards policy makers should consider before release of a COVID-19 vaccine, including ensuring effectiveness through clinical trials, providing evidence of safety, requiring informed consent before vaccination, and establishing comprehensive adverse effects monitoring systems.
Michael Klompas, MD, MPH; Meghan A. Baker, MD, ScD; Chanu Rhee, MD, MPH
doi : 10.1001/jama.2020.12458
JAMA. 2020;324(5):441-442.
This Viewpoint discusses physical and epidemiological evidence supporting droplet vs aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and concludes on balance that aerosol transmission seems unlikely to be the dominant mode of coronavirus disease 2019 (COVID-19) spread.
Richard Saitz, MD, MPH; Gary Schwitzer
doi : 10.1001/jama.2020.12535
JAMA. 2020;324(5):443-444.
Tyler J. VanderWeele, PhD
doi : 10.1001/jama.2020.12187
JAMA. 2020;324(5):445-446.
This Viewpoint discusses how COVID-19–related policy decisions lead to trade-offs between medical, economic, social, and psychological outcomes, and emphasizes the need to account for deaths associated with unemployment and depression when estimating excess mortality.
Andrew D. Carlo, MD, MPH; Brian S. Barnett, MD; Richard G. Frank, PhD
doi : 10.1001/jama.2020.3505
JAMA. 2020;324(5):447-448.
This Viewpoint discusses halting progress in legislative and policy attempts to make access to high-quality mental health and substance use disorders service equal to that for medical-surgical services and prospects for further regulation of insurance to achieve the goal.
Michelle D. Carlson, MD; Brita Roy, MD, MPH, MHS; A. Stef Groenewoud, PhD
doi : 10.1001/jama.2020.3813
JAMA. 2020;324(5):449-450.
This Viewpoint discusses differences that complicate cross-country comparisons of health and social services and proposes a framework for assessing the appropriateness of those comparisons to help researchers improve their investigations and help readers critically appraise them.
Randy A. Vince Jr, MD
doi : 10.1001/jama.2020.12432
JAMA. 2020;324(5):451-452.
In this narrative medicine essay, a urology fellow offers 5 actions the medical community should take to eliminate racial injustice and health disparities in the United States.
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Robert M. Golub, MD
doi : 10.1001/jama.2020.11764
JAMA. 2020;324(5):453-454.
Arturo Casadevall, MD, PhD; Michael J. Joyner, MD; Liise-Anne Pirofski, MD
doi : 10.1001/jama.2020.10218
JAMA. 2020;324(5):455-457.
Jody W. Zylke, MD; Howard Bauchner, MD
doi : 10.1001/jama.2020.11761
JAMA. 2020;324(5):458-459.
Sean P. Murphy, MB, BCh, BAO; Nasrien E. Ibrahim, MD; James L. Januzzi Jr, MD
doi : 10.1001/jama.2020.10262
JAMA. 2020;324(5):488-504.
This narrative review summarizes the epidemiology, pathophysiology, diagnosis, management, and prognosis of heart failure with reduced ejection fraction.
doi : 10.1001/jama.2020.0753
JAMA. 2020;324(5):505.
This Medical Letter review describes how tafamidis prevents transthyretin protein complexes from disocciating into amyloid fibrils, and its recent approval in 2 different formulations (Vyndaqel and Vyndamax) for treatment of adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM).
Jennifer Abbasi
doi : 10.1001/jama.2020.11672
JAMA. 2020;324(5):427-429
This Medical News article is an interview with Chicago public health legend and retired physician Linda Rae Murray, MD, MPH, an adjunct assistant professor at the University of Illinois at Chicago School of Public Health and a past president of the American Public Health Association.
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.13100
JAMA. 2020;324(5):433.
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.13103
AMA. 2020;324(5):433.
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.13299
JAMA. 2020;324(5):433.
Larry Levitt, MPP
doi : 10.1001/jama.2020.12248
JAMA. 2020;324(5):431-432
Tracy Hampton, PhD
doi : 10.1001/jama.2020.12669
JAMA. 2020;324(5):430.
Anurag N. Malani, MD; John P. Sherbeck, MD; Preeti N. Malani, MD, MSJ
doi : 10.1001/jama.2020.10699
JAMA. 2020;324(5):524.
Xianshi Zhou, MD; Guanghua Tang, PhD
doi : 10.1001/jama.2020.7980
JAMA. 2020;324(5):515.
Geoff Bellingan, MD, PhD; V. Marco Ranieri, MD; Matti K. Karvonen, MD, PhD
doi : 10.1001/jama.2020.7992
JAMA. 2020;324(5):515-516.
Luis W. Dominguez, MD, MPH; Joel S. Willis, DO, PA, MA, MPhil
doi : 10.1001/jama.2020.8645
JAMA. 2020;324(5):516.
Bart Dierynck, PhD; Philip Joos, PhD
doi : 10.1001/jama.2020.8642
JAMA. 2020;324(5):516-517.
Joseph A. DiMasi, PhD
doi : 10.1001/jama.2020.8648
JAMA. 2020;324(5):517.
Olivier J. Wouters, PhD; Martin McKee, MD, DSc; Jeroen Luyten, PhD
doi : 10.1001/jama.2020.8651
JAMA. 2020;324(5):518.
Zhong Liu, MD, PhD
doi : 10.1001/jama.2020.12607
JAMA. 2020;324(5):518-519.
doi : 10.1001/jama.2020.13216
JAMA. 2020;324(5):519.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟